Biomark Diagnostics Inc. (CSE:BUX)
Canada flag Canada · Delayed Price · Currency is CAD
0.4500
-0.0300 (-6.25%)
Jan 20, 2026, 11:19 AM EST

Biomark Diagnostics Ratios and Metrics

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jan '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
542225151631
Upgrade
Market Cap Growth
265.20%-9.92%60.95%-1.62%-48.77%128.35%
Upgrade
Enterprise Value
542426171731
Upgrade
Last Close Price
0.480.270.300.210.230.42
Upgrade
PS Ratio
439.76145.04152.12100.50356.91-
Upgrade
PB Ratio
62.8612.85-40.73-13.42-24.67-386.98
Upgrade
P/TBV Ratio
62.8612.85----
Upgrade
EV/Sales Ratio
-154.52161.35110.73393.16-
Upgrade
Debt / Equity Ratio
0.930.64-2.54-1.44-3.09-12.70
Upgrade
Asset Turnover
0.090.070.180.140.04-
Upgrade
Quick Ratio
1.732.140.160.060.310.98
Upgrade
Current Ratio
1.732.140.160.080.331.00
Upgrade
Return on Equity (ROE)
--340.70%----
Upgrade
Return on Assets (ROA)
-79.14%-60.59%-117.29%-104.38%-66.20%-80.77%
Upgrade
Return on Capital Employed (ROCE)
-197.50%-107.60%1099.30%197.40%4328.70%-3366.60%
Upgrade
Earnings Yield
-3.05%-8.62%-5.75%-11.94%-9.27%-3.57%
Upgrade
FCF Yield
-2.62%-4.90%-3.98%-5.96%-8.06%-2.64%
Upgrade
Buyback Yield / Dilution
-10.10%-6.67%-2.97%-6.22%-6.31%-2.82%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.